Disclosed positions

Estimated from their latest filings — positions may have changed since

$113.1K

combined est. value

Stock	Shares	Price	Value	Weight	As of
TCRTAlaunos Therapeutics, Inc.	58,609	$1.93	$113.1K	100%	2026-07-23

TCRT

Alaunos Therapeutics, Inc.

$113.1K

58,609 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
TCRTAlaunos Therapeutics, Inc.	Grant $16.2K · 8,463 sh	2026-07-23	—
TCRTAlaunos Therapeutics, Inc.	Grant $16.2K · 5,622 sh	2026-01-12	—
TCRTAlaunos Therapeutics, Inc.	Grant $16.2K · 5,142 sh	2025-11-21	—
TCRTAlaunos Therapeutics, Inc.	Grant — · 4,050 sh	2025-07-03	—
TCRTAlaunos Therapeutics, Inc.	Grant $60.7K · 20,804 sh	2025-04-13	—

TCRTGrant

2026-07-23 · Alaunos Therapeutics, Inc.

$16.2K

—

TCRTGrant

2026-01-12 · Alaunos Therapeutics, Inc.

$16.2K

—

TCRTGrant

2025-11-21 · Alaunos Therapeutics, Inc.

$16.2K

—

TCRTGrant

2025-07-03 · Alaunos Therapeutics, Inc.

4,050

—

TCRTGrant

2025-04-13 · Alaunos Therapeutics, Inc.

$60.7K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.